FDA Advisors Endorse Moderna's COVID-19 Vaccine Booster for Some Groups
Summary from the AllSides News Team
A Food and Drug Administration (FDA) advisory panel voted unanimously on Thursday to recommend the agency let certain groups of Americans get Moderna’s COVID-19 vaccine booster shot.
The 19–0 vote followed an all-virtual meeting that featured hours of discussions, presentations and deliberations over who should qualify. The panel ultimately advised the FDA to release the shots for people 65 and older, people ages 18 to 64 deemed to be at high-risk of contracting severe Covid-19, and people with jobs that put them at high risk of severe COVID-19. The recommendation followed the FDA's approval of Pfizer's booster shot late last month. The agency general follows guidance from its advisory panels, though it's not required to.
Coverage was prominent and similar across the political spectrum. Many reports highlighted how some panelists were still skeptical of the immediate need for the shots but ended up endorsing them anyway.
Featured Coverage of this Story
From the Center
FDA advisory panel unanimously endorses Moderna’s Covid vaccine booster for some groups
AFood and Drug Administration advisory panel voted unanimously Thursday in favor of authorizing booster shots of the Moderna Covid-19 vaccine to people 65 and older, those 18 to 64 with risk factors for severe Covid-19, and those whose jobs put them at high risk of serious complications of Covid-19, such as health care workers.
After hours of deliberation, the Vaccines and Related Biological Products Advisory Committee voted 19-to-0 that the Moderna booster should be authorized for these groups. The panel also discussed at what point boosters should be recommended to...
From the Left
FDA vaccine advisers recommend emergency use authorization for booster dose of Moderna's Covid-19 vaccine
Vaccine advisers to the US Food and Drug Administration voted unanimously Thursday to recommend emergency use authorization of a booster dose of Moderna's Covid-19 vaccine.
The FDA's Vaccines and Related Biological Products Advisory Committee agreed use of a booster dose would be safe and effective in some people six months out from their primary series.
Moderna had asked for emergency use authorization for a half dose of its vaccine to be used as a booster for certain people.
All 19 members of the committee supported authorizing a 50-microgram booster dose...
From the Right
FDA Panel Unanimously Recommends Authorization of Moderna COVID-19 Vaccine Booster
A Food and Drug Administration (FDA) advisory panel voted unanimously on Thursday to recommend the agency let millions of Americans get a booster of Moderna’s COVID-19 vaccine.
The 19–0 vote came after hours of discussions and presentations in an all-virtual meeting.
Moderna officials presented data from clinical trials, including a small trial that studied the safety and effectiveness of a booster, as did officials from Israel, one of the first countries in the world to start giving boosters, and the FDA, which performed an analysis of Moderna’s data but did not support...
AllSides Picks
April 18th, 2024
April 18th, 2024
April 18th, 2024
More News about Coronavirus from the Left, Center and Right
From the Left
From the Center
From the Right
